Invesco Health Care Fund Class Y (GGHYX)
| Fund Assets | 1.47B |
| Expense Ratio | 0.81% |
| Min. Investment | $1,000 |
| Turnover | n/a |
| Dividend (ttm) | 1.84 |
| Dividend Yield | 4.85% |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 16, 2024 |
| Previous Close | 37.51 |
| YTD Return | 1.97% |
| 1-Year Return | -0.36% |
| 5-Year Return | 29.16% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | n/a |
| Holdings | 82 |
| Inception Date | Oct 3, 2008 |
About GGHYX
The Fund's investment strategy focuses on GL Health/Biotech with 0.81% total expense ratio. The minimum amount to invest in AIM Investment Funds (Invesco Investment Funds): Invesco Health Care Fund; Class Y Shares is $1,000 on a standard taxable account. AIM Investment Funds (Invesco Investment Funds): Invesco Health Care Fund; Class Y Shares seeks long-term growth of capital. GGHYX invests, under normal circumstances, at least 80% of its net assets in securities of issuers engaged primarily in health care-related industries, and in derivatives and other instruments that have economic characteristics similar to such securities.
Performance
GGHYX had a total return of -0.36% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.30%.
Top 10 Holdings
51.20% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.88% |
| Boston Scientific Corporation | BSX | 8.83% |
| Intuitive Surgical, Inc. | ISRG | 5.74% |
| UnitedHealth Group Incorporated | UNH | 5.53% |
| Stryker Corporation | SYK | 4.54% |
| AbbVie Inc. | ABBV | 4.09% |
| Vertex Pharmaceuticals Incorporated | VRTX | 3.95% |
| Cencora, Inc. | COR | 3.61% |
| Abbott Laboratories | ABT | 2.81% |
| argenx SE | ARGX | 2.22% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2024 | $1.8353 | Dec 16, 2024 |
| Dec 16, 2021 | $9.9297 | Dec 16, 2021 |
| Dec 15, 2020 | $0.5793 | Dec 15, 2020 |
| Dec 13, 2019 | $1.5683 | Dec 13, 2019 |
| Dec 14, 2018 | $2.9024 | Dec 14, 2018 |
| Dec 13, 2017 | $2.4481 | Dec 13, 2017 |